Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126561511 | 12656151 | 1 | I | 2016 | 20160810 | 20160816 | 20160816 | EXP | US-PFIZER INC-2016383365 | PFIZER | 65.00 | YR | F | Y | 92.30000 | KG | 20160816 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126561511 | 12656151 | 1 | PS | AROMASIN | EXEMESTANE | 1 | Oral | 25 MG, 1X/DAY | 20753 | 25 | MG | COATED TABLET | QD | ||||||
| 126561511 | 12656151 | 2 | C | PROGRAF | TACROLIMUSTACROLIMUS ANHYDROUS | 1 | 1 MG, 2X/DAY | 0 | 1 | MG | BID | ||||||||
| 126561511 | 12656151 | 3 | C | CELLCEPT | MYCOPHENOLATE MOFETILMYCOPHENOLATE MOFETIL HYDROCHLORIDE | 1 | 250 MG, 2X/DAY | 0 | 250 | MG | BID | ||||||||
| 126561511 | 12656151 | 4 | C | METOPROLOL. | METOPROLOL | 1 | 100 MG, 2X/DAY | 0 | 100 | MG | BID | ||||||||
| 126561511 | 12656151 | 5 | C | HYDRALAZINE | HYDRALAZINE HYDROCHLORIDE | 1 | UNK, 3X/DAY | 0 | TID | ||||||||||
| 126561511 | 12656151 | 6 | C | CLONIDINE. | CLONIDINE | 1 | 0.2 MG, 3X/DAY | 0 | .2 | MG | TID | ||||||||
| 126561511 | 12656151 | 7 | C | LOPRESSOR | METOPROLOL TARTRATE | 1 | UNK | 0 | |||||||||||
| 126561511 | 12656151 | 8 | C | Gliburide | 2 | 5 MG, 2X/DAY | 0 | 5 | MG | BID | |||||||||
| 126561511 | 12656151 | 9 | C | LANTUS | INSULIN GLARGINE | 1 | 25 IU, 1X/DAY | 0 | 25 | IU | QD | ||||||||
| 126561511 | 12656151 | 10 | C | ASPIRIN /00002701/ | ASPIRIN | 1 | 81 MG, 1X/DAY | 0 | 81 | MG | QD | ||||||||
| 126561511 | 12656151 | 11 | C | PROTONIX | PANTOPRAZOLE SODIUM | 1 | 40 MG, 1X/DAY | 0 | 40 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126561511 | 12656151 | 1 | Breast cancer |
| 126561511 | 12656151 | 2 | Prophylaxis against transplant rejection |
| 126561511 | 12656151 | 3 | Prophylaxis against transplant rejection |
| 126561511 | 12656151 | 4 | Hypertension |
| 126561511 | 12656151 | 5 | Hypertension |
| 126561511 | 12656151 | 6 | Hypertension |
| 126561511 | 12656151 | 7 | Blood cholesterol abnormal |
| 126561511 | 12656151 | 8 | Diabetes mellitus |
| 126561511 | 12656151 | 9 | Diabetes mellitus |
| 126561511 | 12656151 | 10 | Cardiac disorder |
| 126561511 | 12656151 | 11 | Gastrooesophageal reflux disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126561511 | 12656151 | OT |
| 126561511 | 12656151 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126561511 | 12656151 | Blood creatinine increased | |
| 126561511 | 12656151 | Blood magnesium decreased | |
| 126561511 | 12656151 | Blood potassium increased | |
| 126561511 | 12656151 | Depression | |
| 126561511 | 12656151 | Dyspnoea | |
| 126561511 | 12656151 | Pulmonary oedema | |
| 126561511 | 12656151 | Respiratory tract infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126561511 | 12656151 | 1 | 201505 | 0 | ||
| 126561511 | 12656151 | 2 | 200911 | 0 | ||
| 126561511 | 12656151 | 3 | 2010 | 0 |